The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for patients seeking to treat obesity. Today, a month's supply of weight loss drugs can cost $1,000 or more, according to estimates from a White House official. About 72 million Americans were enrolled in Medicaid as of July, according to the Centers for Medicare & Medicaid Services. Research suggests there are significant disparities in who receives weight loss drugs. Weight loss drugs like Wegovy are injectable medications of semaglutide.

---

Persons: Dr, Laure DeMattia Organizations: Biden, White, Centers for Disease Control, White House, Centers, Medicare, Medicaid Services, Kaiser Family Foundation . Research, NBC News, Health Affairs Locations: Norman , Oklahoma, U.S